Recombinant Human CCL4/MIP-1-beta Protein, N-GST (PX-P5545)
概述
图片
参考文献
概述
货号
PX-P5545
品牌
ProteoGenix
描述
Recombinant Human CCL4/MIP-1-beta Protein, N-GST (PX-P5545) expressed in E. coli, Purity: >90% as determined by SDS-PAGE..
Highlights
High Purity (>90% as determined by SDS-PAGE.) — Verified by SDS-PAGE for downstream accuracy.
E. coli Expression — Optimized for functional studies.
表达系统
E. coli
Accession号
P13236
蛋白长度
Ala24-Asn92
应用
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
种属
Homo sapiens (Human)
性质
Recombinant
内毒素水平
Please contact with the lab for this information.
纯度
>90% as determined by SDS-PAGE.
预测分子量
34.62 kDa
状态
Lyophilized
保存溶液
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
重悬
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
运输
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
稳定性和存储
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
别名
MIP-1-beta(1-69), MIP-1-beta, C-C motif chemokine 4, Protein H400, ACT-2, HC21, T-cell activation protein 2, Lymphocyte activation gene 1 protein, LAG-1, SIS-gamma, Small-inducible cytokine A4, G-26 T-lymphocyte-secreted protein, Macrophage inflammatory protein 1-beta, LAG1, PAT 744, CCL4, SCYA4, MIP1B
背景
C-C motif chemokine 4 (CCL4/MIP-1-beta) is a ~10 kDa protein. Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells.
